Pyridam Farma Tbk PT
IDX:PYFA
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
89
1 400
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Pyridam Farma Tbk PT
Pyridam Farma Tbk PT
Common Shares Outstanding
Pyridam Farma Tbk PT
Common Shares Outstanding Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Pyridam Farma Tbk PT
IDX:PYFA
|
Common Shares Outstanding
Rp11.2B
|
CAGR 3-Years
176%
|
CAGR 5-Years
84%
|
CAGR 10-Years
36%
|
|
|
T
|
Tempo Scan Pacific Tbk PT
IDX:TSPC
|
Common Shares Outstanding
Rp4.5B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
Kalbe Farma Tbk PT
IDX:KLBF
|
Common Shares Outstanding
Rp46.2B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
|
Common Shares Outstanding
Rp1.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
Soho Global Health Tbk PT
IDX:SOHO
|
Common Shares Outstanding
Rp12.7B
|
CAGR 3-Years
0%
|
CAGR 5-Years
78%
|
CAGR 10-Years
N/A
|
|
|
Kimia Farma Tbk PT
IDX:KAEF
|
Common Shares Outstanding
Rp5.6B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
Pyridam Farma Tbk PT
Glance View
PT Pyridam Farma Tbk engages in the production and development of pharmaceutical medicines, and trading of medical supplies. The company is headquartered in Jakarta, Dki Jakarta and currently employs 1,539 full-time employees. The company went IPO on 2001-10-16. The firm operates through two segments: Pharmaceutical Products and Toll Manufacturing Services, and Medical Device Products. Its business consists of production and/or distribution of modern and traditional medicines and distribution of medical devices, such as laboratory equipment and PCR test kits. The company offers products across consumer health, prescription, pyfaesthetic and biomedilab categories. The company produces various kinds of pharmaceuticals products ranging from antibiotics, vitamins and health supplements. The firm offers its products in the form of effervescent tablets, capsules, caplets, syrups and creams. Its prescription production has several properties, such as anti-infection, anti-inflammatory, anti-parkinsonian, anti-epileptic, and other indications. The company provides toll manufacturing services to produce products owned by the Company’s partner companies in accordance with predetermined specifications.
See Also
What is Pyridam Farma Tbk PT's Common Shares Outstanding?
Common Shares Outstanding
11.2B
IDR
Based on the financial report for Sep 30, 2024, Pyridam Farma Tbk PT's Common Shares Outstanding amounts to 11.2B IDR.
What is Pyridam Farma Tbk PT's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 10Y
36%
Over the last year, the Common Shares Outstanding growth was 351%. The average annual Common Shares Outstanding growth rates for Pyridam Farma Tbk PT have been 176% over the past three years , 84% over the past five years , and 36% over the past ten years .
You don't have any saved screeners yet
